We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Howmet Aerospace
HWM
$109B
| $20M | 0.05% |
992,185
+40,081
| +4% | +$787K |
|
402
Las Vegas Sands
LVS
$31.4B
| $20M | 0.05% |
350,421
+8,635
| +3% | +$470K |
|
403
Advanced Micro Devices
AMD
$700B
| $20M | 0.05% |
1,374,241
-111,792
| -8% | -$1.42M |
|
404
United Rentals
URI
$65.7B
| $20M | 0.05% |
159,807
+6,852
| +4% | +$834K |
|
405
Bath & Body Works
BBWI
$3.97B
| $19.9M | 0.05% |
522,317
-810
| -0.2% | -$36.5K |
|
406
Universal Health Services
UHS
$10.2B
| $19.8M | 0.05% |
159,437
+8,566
| +6% | +$1.01M |
|
407
Brown-Forman Class B
BF.B
$13.5B
| $19.8M | 0.05% |
671,153
+56,701
| +9% | +$1.69M |
|
408
Jack Henry & Associates
JKHY
$11.4B
| $19.7M | 0.05% |
211,570
+19,400
| +10% | +$1.79M |
|
|
Y
409
DELISTED
Alleghany Corp
Y
| $19.7M | 0.05% |
32,002
+1,950
| +6% | +$1.22M |
|
410
Western Union
WU
$2.53B
| $19.7M | 0.05% |
966,548
+17,308
| +2% | +$353K |
|
411
F5
FFIV
$22B
| $19.6M | 0.05% |
137,666
+2,833
| +2% | +$404K |
|
412
Travel + Leisure Co
TNL
$4.76B
| $19.6M | 0.05% |
514,447
+14,535
| +3% | +$534K |
|
413
Broadridge
BR
$18.4B
| $19.6M | 0.05% |
287,781
+5,998
| +2% | +$407K |
|
|
FRC
414
DELISTED
First Republic Bank
FRC
| $19.5M | 0.05% |
207,538
+22,309
| +12% | +$2.1M |
|
415
Gartner
IT
$11.1B
| $19.4M | 0.05% |
180,109
+10,962
| +6% | +$1.13M |
|
416
iShares Russell 1000 ETF
IWB
$47.1B
| $19.4M | 0.05% |
147,895
+42,494
| +40% | +$5.5M |
|
|
SIVB
417
DELISTED
SVB Financial Group
SIVB
| $19.4M | 0.05% |
104,190
+5,855
| +6% | +$1.06M |
|
|
IPG
418
DELISTED
Interpublic Group of Companies
IPG
| $19.4M | 0.05% |
787,807
+15,936
| +2% | +$382K |
|
|
ANSS
419
DELISTED
Ansys
ANSS
| $19.3M | 0.05% |
180,207
+10,159
| +6% | +$1.02M |
|
|
TIF
420
DELISTED
Tiffany & Co.
TIF
| $19.2M | 0.04% |
201,690
+10,766
| +6% | +$919K |
|
|
JNPR
421
DELISTED
Juniper Networks
JNPR
| $19.2M | 0.04% |
689,375
+7,960
| +1% | +$222K |
|
|
DRE
422
DELISTED
Duke Realty Corp.
DRE
| $19.2M | 0.04% |
729,277
+52,324
| +8% | +$1.35M |
|
423
BioMarin Pharmaceuticals
BMRN
$11.9B
| $19.1M | 0.04% |
217,793
+7,857
| +4% | +$699K |
|
|
WFM
424
DELISTED
Whole Foods Market Inc
WFM
| $19M | 0.04% |
640,617
+27,780
| +5% | +$836K |
|
425
Arthur J. Gallagher & Co
AJG
$69.1B
| $19M | 0.04% |
336,375
+8,613
| +3% | +$475K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.